AI Verdict
PBYI has stronger fundamentals based on our AI analysis.
PCOK vs PBYI Fundamental Comparison
| Metric | PCOK | PBYI |
|---|---|---|
| Revenue | $92.1M | $228.4M |
| Net Income | $-244.1M | $31.1M |
| Net Margin | -265.2% | 13.6% |
| ROE | N/A | 23.9% |
| ROA | -27.6% | 14.4% |
| Current Ratio | N/A | 2.00x |
| Debt/Equity | N/A | 0.17x |
| EPS | $-2.37 | $0.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PCOK vs PBYI: Frequently Asked Questions
Is PCOK or PBYI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PBYI has stronger fundamentals. PCOK is rated STRONG SELL (92% confidence) while PBYI is rated BUY (72% confidence). This is not investment advice.
How does PCOK compare to PBYI fundamentally?
Pacific Oak Strategic Opportunity REIT, Inc. has ROE of N/A vs PUMA BIOTECHNOLOGY, INC.'s 23.9%. Net margins are -265.2% vs 13.6% respectively.
Which stock pays higher dividends, PCOK or PBYI?
PCOK has a dividend yield of N/A or no dividend while PBYI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PCOK or PBYI for long term?
For long-term investing, consider that PCOK has STRONG SELL rating with 92% confidence, while PBYI has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PCOK vs PBYI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCOK vs PBYI, the AI consensus favors PBYI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.